FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,379,000 | +65.1% | 294,118 | 0.0% | 0.07% | +53.3% |
| Q2 2022 | $1,441,000 | -79.3% | 294,118 | 0.0% | 0.04% | -67.6% |
| Q1 2022 | $6,956,000 | -33.2% | 294,118 | -50.0% | 0.14% | +73.8% |
| Q4 2021 | $10,406,000 | +25.4% | 588,236 | +100.0% | 0.08% | -33.9% |
| Q3 2021 | $8,297,000 | +34.6% | 294,118 | -50.0% | 0.12% | +202.5% |
| Q2 2021 | $6,164,000 | -60.9% | 588,236 | -34.2% | 0.04% | -84.4% |
| Q2 2020 | $15,768,000 | +120.1% | 894,118 | +49.0% | 0.26% | +36.9% |
| Q1 2020 | $7,164,000 | -28.2% | 600,000 | 0.0% | 0.19% | -5.6% |
| Q4 2019 | $9,984,000 | +150.6% | 600,000 | 0.0% | 0.20% | +85.0% |
| Q3 2019 | $3,984,000 | – | 600,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |